David Segal
Pediatric Endocrinology · Fort Wayne, INNPI 1720730419
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 69.7% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $3,878, more than ten times the $381 reported in 2022.
Across 77 payments — averaging $84.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Insulet Corporation$427
- Ascendis Pharma Endocrinology Inc$308
- Sanofi-aventis U.S. LLC$281
- Abbott$121
- Neurocrine Biosciences, Inc.$105
- plus $739 from 17 others
What the payments were for
- Speaking & faculty fees$2,50038%
- Travel & lodging$5959%
- Food & beverage$3,43653%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 23 | $4,550 |
| Insulet Corporation | 6 | $427 |
| Ascendis Pharma Endocrinology Inc | 9 | $308 |
| Sanofi-aventis U.S. LLC | 5 | $281 |
| Abbott | 2 | $121 |
| Neurocrine Biosciences, Inc. | 4 | $105 |
| Eton Pharmaceuticals, Inc. | 1 | $91 |
| Sequel Med Tech, LLC | 1 | $86 |
| Regeneron Healthcare Solutions, Inc. | 4 | $83 |
| BETA Bionics, Inc. | 1 | $70 |
| Xeris Pharmaceuticals, Inc. | 4 | $60 |
| Pfizer | 3 | $57 |
| Azurity Pharmaceuticals, Inc. | 2 | $50 |
| Soleno Therapeutics, Inc. | 2 | $48 |
| Dexcom, Inc. | 2 | $45 |
| Endo USA, Inc. | 1 | $28 |
| Biomarin Pharmaceutical Inc. | 1 | $22 |
| Tolmar Pharmaceuticals, Inc. | 1 | $21 |
| Mannkind Corporation | 1 | $18 |
| Novo Nordisk | 1 | $18 |
| Tolmar, Inc. | 1 | $16 |
| Ultragenyx Pharmaceutical Inc. | 1 | $13 |
| Albireo Pharma, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$3,568
- INPEN SMART INSULIN DELIVERY SYSTEM$259
- Omnipod$223
- SKYTROFA$109
How this compares
$6,531 in reported general payments places this provider in the 55th percentile of 27 pediatric endocrinology providers in Indiana.
Other pediatric endocrinology in Fort Wayne
- Gordon CutlerIndianapolis$305K
- Emily SimsIndianapolis$236K
- Linda di MeglioIndianapolis$96K
- Erik ImelIndianapolis$69K
- Jamie FeltonIndianapolis$34K
- Erica EugsterIndianapolis$21K
- John FuquaIndianapolis$20K
- Farah KhatoonSouth Bend$18K
- Rebecca AguirreIndianapolis$13K
- Hebatullah IsmailIndianapolis$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.